Psilocybin or "magic mushrooms" are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. (Photo/Agencies)
"Magic mushrooms" may have moved one step closer to becoming a treatment for depression. The active ingredient in psychedelic mushrooms is called psilocybin-and a new British study suggests it could safely be used to treat depression when other drugs have failed, offering hope to millions of patients worldwide. The study, conducted by King's College London and mental healthcare company Compass Pathways, administered psilocybin to 89 healthy adult volunteers.
Psilocybin or "magic mushrooms" are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. (Photo/Agencies)
